APA 6th Edition Šekerija, M. i Čukelj, P. (2015). Epidemiology of ovarian cancer in Croatia. Libri Oncologici, 43 (1-3), 3-8. Preuzeto s https://hrcak.srce.hr/189798
MLA 8th Edition Šekerija, Mario i Petra Čukelj. "Epidemiology of ovarian cancer in Croatia." Libri Oncologici, vol. 43, br. 1-3, 2015, str. 3-8. https://hrcak.srce.hr/189798. Citirano 23.07.2019.
Chicago 17th Edition Šekerija, Mario i Petra Čukelj. "Epidemiology of ovarian cancer in Croatia." Libri Oncologici 43, br. 1-3 (2015): 3-8. https://hrcak.srce.hr/189798
Harvard Šekerija, M., i Čukelj, P. (2015). 'Epidemiology of ovarian cancer in Croatia', Libri Oncologici, 43(1-3), str. 3-8. Preuzeto s: https://hrcak.srce.hr/189798 (Datum pristupa: 23.07.2019.)
Vancouver Šekerija M, Čukelj P. Epidemiology of ovarian cancer in Croatia. Libri Oncologici [Internet]. 2015 [pristupljeno 23.07.2019.];43(1-3):3-8. Dostupno na: https://hrcak.srce.hr/189798
IEEE M. Šekerija i P. Čukelj, "Epidemiology of ovarian cancer in Croatia", Libri Oncologici, vol.43, br. 1-3, str. 3-8, 2015. [Online]. Dostupno na: https://hrcak.srce.hr/189798. [Citirano: 23.07.2019.]
Sažetak Ovarian cancer is one of the most lethal malignant cancers in women, mainly because of the late stage at diagnosis. It is the seventh most common cancer in women in the world in incidence (239,000,3.6%) andeighth in mortality (152,000,4.3%). More developed regions have higher incidence and mortality rates than developing countries.
In Croatia, ovarian cancer ranks as the sixth most common cancer in women (430 new cases in 2013) and the sixth malignant cause of death (328 deaths in 2013). Research based on the Croatian National Cancer Registry data also shows that trends of standardized incidence and mortality rates for ovarian cancer in Croatia are relatively stable for the period from 1988 to 2008, while recent studies oncancer survival (EUROCARE-5, CONCORD-2) rank Croatia close to the European
mean when it comes to ovarian cancer survival.
Ovarian cancer is asignifi cant public health burden in Croatia. Eff orts should be put in education about symptoms, and some modifi able risk factors such as tobacco use, obesity and hormone replacement therapy.